| Literature DB >> 19565267 |
Rodrigo Rosario-Cruz1, Felix D Guerrero, Robert J Miller, Roger Ivan Rodriguez-Vivas, Mary Tijerina, Delia Ines Dominguez-Garcia, Ruben Hernandez-Ortiz, Anthony J Cornel, Rory D McAbee, Miguel Angel Alonso-Diaz.
Abstract
Susceptibility to synthetic pyrethroids (SP s) and the role of two major resistance mechanisms were evaluated in Mexican Rhipicephalus microplus tick populations. Larval packet test (LPT), knock-down (kdr) PCR allele-specific assay (PASA) and esterase activity assays were conducted in tick populations for cypermethrin, flumethrin and deltamethrin. Esterase activity did not have a significant correlation with SP s resistance. However a significant correlation (p < 0.01) was found between the presence of the sodium channel mutation, and resistance to SP s as measured by PASA and LPT respectively. Just over half the populations (16/28) were cross-resistant to flumethrin, deltamethrin and cypermethrine, 21.4% of the samples (6/28) were susceptible to all of the three pyrethroids 10.7 of the samples (3/28) were resistant to flumethrin, 3.4 of the samples (1/28) were resistant to deltamethrin only and 7.1% (2/28) were resistant to flumethrin and deltamethrin. The presence of the kdr mutation correlates with resistance to the SP s as a class. Target site insensitivity is the major mechanism of resistance to SP s in Mexican R. microplus field strains, involving the presence of a sodium channel mutation, however, esterase-based, other mutations or combination of mechanisms can also occur.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19565267 PMCID: PMC2729983 DOI: 10.1007/s00436-009-1539-1
Source DB: PubMed Journal: Parasitol Res ISSN: 0932-0113 Impact factor: 2.289
Esterase activity, survival rate to three pyrethroid compounds, specific Kdr genotypes and overall frequencies of RR + RS genotypes, in different populations of R. microplus ticks from the state of Yucatán, México
| Strain | Esterases U/L | Survival flumethrin% | Survival deltamethrin% | Survival cypermethrin% | NO. OF LARVAE WITH SPECIFIC | % OF LARVAE WITH SPECIFIC GENOTYPE | % of RR + RS genotype | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SS | SR | RR | SS | SR | RR | ||||||
| A-P67 | 3.14 | 0 | 0 | 0 | 47/50 | 3 | 0 | 94 | 6 | 0 | 6 |
| B-B74 | 1.31 | 0 | 0 | 0 | 45 | 2 | 1 | 93.75 | 4.17 | 2.08 | 6.25 |
| C-P65 | 1.73 | 10.6 | 8.05 | 0 | 40 | 5 | 0 | 88.89 | 11.11 | 0 | 11.11 |
| D-T11 | 1.62 | 24.57 | 21.3 | 18.88 | 32 | 12 | 6 | 65.31 | 24.49 | 12.24 | 36.73 |
| E-M10 | 2.29 | 19.32 | 24.65 | 17.91 | 17 | 25 | 8 | 34 | 50 | 16 | 66 |
| F-C54 | 3.02 | 17.21 | 20.22 | 16.43 | 32 | 12 | 6 | 64 | 24 | 12 | 36 |
| G-R49 | 3.02 | 98.22 | 99.81 | 95.58 | 4 | 46 | 0 | 8 | 92 | 0 | 92 |
| H-B71 | 0.96 | 100 | 88.6 | 100 | 7 | 32 | 11 | 14 | 64 | 22 | 86 |
| I-T66 | 1.98 | 100 | 100 | 100 | 1 | 7 | 42 | 2 | 14 | 84 | 98 |
| J-004 | 5 | 2.03 | 3.68 | 2.99 | 9 | 0 | 0 | 100 | 0 | 0 | 0 |
| K-007 | 2.89 | 54.72 | 70.28 | 55.24 | 7 | 16 | 2 | 28 | 64 | 8 | 72 |
| L-008 | 2.46 | 61.7 | 51.72 | 52.59 | 1 | 10 | 13 | 4.17 | 41.67 | 54.17 | 95.83 |
| M-012 | 2.62 | 0 | 0 | 0 | 22 | 1 | 0 | 95.65 | 4.35 | 0 | 4.35 |
| O-014 | 1.3 | 8.04 | 4.95 | 7.92 | 19 | 2 | 3 | 79.17 | 8.33 | 12.5 | 20.83 |
| P-015 | 1.7 | 5.3 | 2.9 | 1.87 | 14 | 2 | 7 | 60.87 | 8.7 | 30.43 | 39.13 |
| Q-051 | 1.67 | 0 | 0 | 0 | 22 | 2 | 1 | 88 | 8 | 4 | 12 |
| R-052 | 2.47 | 14.11 | 14.22 | 6.35 | 24 | 1 | 0 | 96 | 4 | 0 | 4 |
| S-053 | 2 | 5.29 | 0 | 0 | 18 | 3 | 1 | 81.82 | 13.64 | 4.55 | 18.18 |
| T-055 | 2.71 | 1.89 | 0 | 0 | 20 | 3 | 1 | 83.33 | 12.5 | 4.17 | 16.67 |
| U-056 | 3.03 | 45.89 | 51.6 | 64.26 | 1 | 3 | 19 | 4.35 | 13.04 | 82.61 | 95.65 |
| V-057 | 2.73 | 3.38 | 0 | 0 | 18 | 4 | 0 | 81.82 | 18.18 | 0 | 18.18 |
| W-058 | 3.25 | 10.48 | 11.7 | 12.04 | 11 | 13 | 1 | 44 | 52 | 4 | 56 |
| X-059 | 2.34 | 64.66 | 60.63 | 64.07 | 0 | 6 | 19 | 0 | 24 | 76 | 100 |
| Y-060 | 2.06 | 0 | 0 | 0 | 24 | 0 | 0 | 100 | 0 | 0 | 0 |
| Z-061 | 1.98 | 0 | 0 | 0 | 25 | 0 | 0 | 100 | 0 | 0 | 0 |
| AB-063 | 5.56 | 12.5 | 13.37 | 10.56 | 22 | 1 | 2 | 88 | 4 | 8 | 12 |
| BC-064 | 2.49 | 0 | 6.85 | 0 | 25 | 0 | 0 | 100 | 0 | 0 | 0 |
| CD-073 | 2.13 | 31.15 | 17.95 | 15.68 | 12 | 6 | 6 | 50 | 25 | 25 | 50 |
Fig. 1Graph bar showing frequency distribution of different types of susceptibility to pyrethroids as measured by LPT using a discriminant dose for each pyrethroid. Data show percentage obtained from 28 samples collected in Yucatán, Mexico. Py = Pyrethroid resistance, F = flumethrin, D = Deltamethrin, C = cypermethrin, F-D-C = resistance to flumethrin, deltamethrin and cypermethrin, 00 = susceptibility to pyrethroids as a class
Fig. 2Correlation (p > 0.05) between the survival rate as measured by LPT and general esterase activity measured by photocolorimetric assay in international units/liter (U/L) for flumethrin (r2 = 0.0157) (a), deltamethrin (r2 = 0.0043) (b) and cypermethrin (r2 = 0.0081) (c) (P > 0,05)
Fig. 3Correlation (p < 0.01) between the survival rate (%) as measured by the LPT and the (RR + RS) genotype frequency (%) for flumethrin (r2 = 0.77) (a), deltamethrin (r2 = 0.76) (b) and cypermethrin (r2 = 0.78) (c), as measured by the PASA